[1] CAI J,TIAN AX,WANG QS,et al.FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer[J].Cancer Lett,2015,367(2):129.
[2] NIER EL,ROCHA-SALES B,LAUAND C,et al.The multiple facets of drug resistance:one history,different approaches[J].J Exp Clin Cancer Res 2014,2014,33(1):37.
[3] GOIDHIRSCH A,WOOD WC.Strategies for subtypes-dealing with the diversity of breast cancer:highlights of the St.Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J].Ann Oncol,2011,22(8):1736.
[4] MO W,ZHANG JT.Human ABCG2:structure,function,and its role in multidrug resistance[J].Int J Biochem Mol Biol,2012,3(1):1.
[5] STACY AE,JANSSON PJ,RICHARDSON DR.Molecular pharmacology of ABCG2 and its role in chemoresistance[J].Mol Pharmacol,2013,84(5):655.
[6] 王兴,姜真,孙长岗.乙醛脱氢酶1与乳腺癌耐药蛋白在乳腺癌中的表达及相关性研究[J].中国癌症杂志,2014,24(3):175.
[7] 梁茱,付生苗.乳腺癌耐药基因的研究进展和临床应用[J].中国热带医学,2011,11(4):511.
[8] XIANG L,SU P,XIA SJ,et al.ABCG2 is associated with HER-2 expression,lymph node metastasis and clinical stage in breast invasive ductal carcinoma[J].Diagn Pathol,2011,6:90.
[9] BARANWAL S,ALAHARI SK.Molecular mechanisms controlling E-cadherin expression in breast cancer[J].Biochem Biophys Res Commun,2009,384(1):6.
[10] ZHANG JC,LIANG Q,LEI Y,et al.SOX4 induces epithelial-mesenchymal transition and contributes to Breast Cancer progression[J].Cancer Research,2012,72(17):4597.
[11] NAKANISHI T,ROSS DD.Breast cancer resistance protein(BCRP/ABCG2):its role in multidrug resistance and regulation of its gene expression[J].Chin J Cancer,2012,31(2):73.
[12] WESTOVER D,LI F.New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapies[J].J Exp Clin Cancer Res,2015,34:159.
[13] BONAVIDA B,BARITAKI S.The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry[J].Crit Rev Oncog,2011,16(3/4):211.
[14] 陈伟娟,王辉,唐勇,等.乳腺癌上皮-间质转化后引发BCRP介导的多药耐药的研究[J].癌症,2010,29(2):159.
[15] EHATA S,JOHANSSON E,KATAYAMA R,et al.Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells[J].Oncogene,2011,30(14):1693.
[16] WANG Y,ZHOU BP.Epithelial-mesenchymal transition in breast cancer progression and metastasis[J].Chin J Cancer,2011,30(9):603.